HeadInvest LLC’s NeoGenomics NEO Stock Holding History

HeadInvest LLC’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-40	Closed	-$476	–	518
2023 Q3	$476	Buy	+40	New	+$595	﹤0.01%	731

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

HeadInvest LLC's NEO Position: Q4 2023 in Review

HeadInvest LLC sold out of NeoGenomics (NEO) in Q4 2023, closing a stake of 40 shares — an estimated $476 sold.

HeadInvest LLC first reported a position in NEO in Q3 2023 and held it in 1 quarter. The position peaked at $476 in Q3 2023. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.

HeadInvest LLC reported no remaining NeoGenomics position as of Q4 2023 after selling out during the quarter.
HeadInvest LLC sold 40 NeoGenomics shares in Q4 2023, an estimated $476.
HeadInvest LLC first reported a position in NeoGenomics in Q3 2023 and held it in 1 quarter.
HeadInvest LLC's NeoGenomics position peaked at $476 in Q3 2023.
287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.

Based on HeadInvest LLC's 13F filing for Q4 2023, filed 12 Feb 2024.